Coronary artery disease, the major manifestation of atherosclerosis, is the leading cause of death in the Western world. In spite of this striking impact, the pathogenesis of atherosclerosis is till poorly understood. Controversy exists regarding the participation of innate immunity involving macrophages. (Mphi) and natural killer (NK) cells versus antigen-specific acquired immunity involving lymphocytes. Mphi predominate in atherosclerotic lesions. NK cells, although smaller in number a present as well. Furthermore the T lymphocytes that participate in acquired immunity are frequently observed in lesions and have been demonstrated to modulate lesion progression. This proposal will address directly the participation of the innate inflammatory and acquired immune responses in vivo. To demonstrate the participation of NK cells in atherosclerosis resulting from moderate as well as profound hypercholesterolemia, we will combine the use of well characterized mouse models of atherosclerosis with inbred strains of mice that are deficient in T and B cell and / or NK cell function.
Our first aim i s to detail the frequency and the kinetics of NK cell and T cell localization within lesions of apolipoprotein E-deficient (apo E -/-) and low density lipoprotein receptor-deficient (LDL-R-/-) mice with both moderate and severe hypercholesterolemia.
This aim will determine the degree to which NK cells and T lymphocytes influence the progression of ahteroma and reveal whether T and NK cell cytokine expression are responsible for the characteristic pathology of the disease. Because the participation of NK cells will be examined in both immune-competent as well as severely immune-deficient animals, these studies will provide valuable information on the participation of NK cells will be examined in both immune-competent as well as severely immune-deficient animals, these studies will provide valuable information on the participation of both innate and acquired immune responses in atherosclerosis.
Our second aim will identify if NK cell and T lymphocyte function within atherosclerotic lesions are influenced by locally produced Mphi apo E. WE have determined that macrophage-derived apo E plays a protective role within the lesions o LDL-r-/- mice and this aim will reveal if regulation of NK cell and/or T cell function is a mechanism by which apo E bestows this protection. The successful completion of these studies will provide critical data about the role of T cells and/or NK cells in arherosclerosis that will aid in the development of new treatment strategies to alter the course of atherosclerosis in humans.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL035297-15
Application #
6388984
Study Section
Pathology A Study Section (PTHA)
Program Officer
Tolunay, Eser
Project Start
1988-12-01
Project End
2003-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
15
Fiscal Year
2001
Total Cost
$302,215
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Petrovan, Ramona J; Yuan, Yuan; Curtiss, Linda K (2008) Expression of the Lyst(beige) mutation is atheroprotective in chow-fed apolipoprotein E-deficient mice. J Lipid Res 49:429-37
Mullick, Adam E; Soldau, Katrin; Kiosses, William B et al. (2008) Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med 205:373-83
Petrovan, Ramona J; Kaplan, Charles D; Reisfeld, Ralph A et al. (2007) DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 27:1095-100
Boisvert, William A; Rose, David M; Johnson, Kristen A et al. (2006) Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol 168:1385-95
Mullick, Adam E; Tobias, Peter S; Curtiss, Linda K (2006) Toll-like receptors and atherosclerosis: key contributors in disease and health? Immunol Res 34:193-209
Mullick, Adam E; Tobias, Peter S; Curtiss, Linda K (2005) Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 115:3149-56
Wiedmer, Therese; Zhao, Ji; Li, Lilin et al. (2004) Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3). Proc Natl Acad Sci U S A 101:13296-301
Binder, Christoph J; Hartvigsen, Karsten; Chang, Mi-Kyung et al. (2004) IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 114:427-37
Schiller, Natalie K; Black, Audrey S; Bradshaw, Gary P et al. (2004) Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice. J Lipid Res 45:1398-409
Schiller, Natalie K; Boisvert, William A; Curtiss, Linda K (2002) Inflammation in atherosclerosis: lesion formation in LDL receptor-deficient mice with perforin and Lyst(beige) mutations. Arterioscler Thromb Vasc Biol 22:1341-6

Showing the most recent 10 out of 40 publications